Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating tumor cells in breast cancer beyond the genotype of primary tumor for tailored therapy.

International journal of cancer - 1 Apr 2016

Ren Chuanli, Han Chongxu, Fu Deyuan, Wang Daxin, Chen Hui, Chen Yong, Shen Ming

Abstract excerpt

Although TNM staging based on tumor, node lymph status and metastasis status-is the most widely used method in the clinic to classify breast cancer (BC) and assess prognosis, it offers limited information for different BC subgroups. Circulating tumor cells (CTCs) are regarded as minimal residual disease and are proven to have a strong relationship with BC. Detection of ≥5 CTCs per 7.5 mL in peripheral blood...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Genotype
Share to Neoplasm Staging

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplastic Cells, Circulating

Source

Identifiers

PMID: 26178386
DOI: 10.1002/ijc.29679

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circulating tumor cells in breast cancer beyond the genotype of primary tumor for tailored therapy.PMID 26178386Read ↗

Circulating tumor cells in breast cancer: functional heterogeneity, pathogenetic and clinical aspects.Semantic proximity Read ↗

Heterogeneity of Circulating Tumor Cells in Breast Cancer: Identifying Metastatic Seeds.Semantic proximity Read ↗

The impact of HER2 phenotype of circulating tumor cells in metastatic breast cancer: a retrospective study in 107 patients.Semantic proximity Read ↗

Circulating Tumor Cells (CTCs) Heterogeneity in Metastatic Breast Cancer: Different Approaches for Different Needs.Semantic proximity Read ↗

Optimizing Detection of Circulating Tumor Cells in Breast Cancer: Unveiling New Markers for Clinical ApplicationsSemantic proximity Read ↗

Molecular heterogeneity in breast cancer: State of the science and implications for patient careSemantic proximity Read ↗

Early Evaluation of Risk Stratification and Clinical Outcomes for Patients with Advanced Breast Cancer through Combined Monitoring of Baseline Circulating Tumor Cells and DNA.Semantic proximity Read ↗

Mutation Analysis of Cell-Free DNA and Single Circulating Tumor Cells in Metastatic Breast Cancer Patients with High Circulating Tumor Cell Counts.Semantic proximity Read ↗

Molecular characterization of breast cancer CTCs associated with brain metastasisSemantic proximity Read ↗

Frequent detection of PIK3CA mutations in single circulating tumor cells of patients suffering from HER2-negative metastatic breast cancer.Semantic proximity Read ↗

Circulating Tumor Cells in Breast Cancer: Correlation with Clinicopathological Parameters, Hormone Profile and MicroRNA Polymorphisms.Semantic proximity Read ↗

New frontiers in circulating tumor cell analysis: A reference guide for biomolecular profiling toward translational clinical useSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.